Low-fiber Diet for Colorectal Cancer Screening Colonoscopy (DIETCOL)

February 14, 2017 updated by: Marco Antonio Alvarez Gonzalez, Parc de Salut Mar

Low-fiber Diet for Colorectal Cancer Screening Colonoscopy. Randomized Clinical Trial. Dietcol Study

This trial will compare the efficacy of 2 different sets of dietary recommendations to be followed before colon cleansing for colorectal cancer screening colonoscopy.

Study Overview

Detailed Description

There is no enough evidence in the literature to recommend a low-fiber diet for screening colonoscopy. Although evidence of benefit of a liquid diet is minimal and there is a growing body of evidence about the benefits of a liberalized diet, a high degree of heterogeneity in the clinical trials comparing the diet modifications before colonoscopy prevents a formal recommendation in current guidelines. A low-fiber diet the day before colonoscopy may result in same efficacy of bowel cleanliness, with an improved tolerability and acceptability.

All consecutive patients of a population-based colorectal screening cancer program referred for a colonoscopy will be invited to participate in the study. After obtaining informed consent, they will be randomized to one of the groups: liquid diet or low-fiber diet. The will be interviewed by a registered research nurse, and they will be provided with written instructions for bowel preparation and questionnaires for registering the data of the study. The day of the colonoscopy, questionnaires will be collected and endoscopists blinded for the study bowel preparation will perform the colonoscopy. Patients will be contacted for adverse events and a general satisfaction questionnaire, 3 days after colonoscopy.

Study Type

Interventional

Enrollment (Actual)

276

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08003
        • Hospital del Mar

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Consecutive patients referred for a colonoscopy in a population-based colorectal screening program.

Exclusion criteria:

  • Unwillingness to participate.
  • Inability to follow instructions
  • Active inflammatory bowel disease
  • Incomplete colonoscopies for technical reasons or contraindication as evaluated by the endoscopist

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low-residue diet
The experimental group will receive 4 days of low-residue diet Laxative 4 liters polyethylene glycol 4000 in split fashion.
Subjects will be instructed by members of the research team to follow a standardized low residue diet for 4 days
Active Comparator: Usual care

The control group will receive 3 days of low-residue diet followed by 24 hours of liquid diet.

Laxative 4 liters polyethylene glycol 4000 in split fashion.

Subjects will be instructed by members of the research team to follow a low-residue diet for 3 days followed by 24 hours of liquid diet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inadequate bowel preparation.
Time Frame: 1 hour after the colonoscopy
The efficacy of bowel preparation will be rated by blinded endoscopists using the Boston Bowel Preparation Scale (BBPS). Colonoscopies with a BBPS score of less than 5 points, or any segment rated less than 2 points will be considered with an inadequate bowel preparation
1 hour after the colonoscopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse events
Time Frame: 30 days after the colonoscopy
Description of all spontaneously reported adverse events.
30 days after the colonoscopy
Adherence to the planned bowel cleansing method (questionnaire)
Time Frame: 6 hours after finishing bowel preparation
Each participant will rate his/her experience in a questionnaire.
6 hours after finishing bowel preparation
Acceptability of the preparation (interference with work, leisure activities or sleep
Time Frame: 6 hours after finishing bowel preparation
Each participant will rate his/her experience in a questionnaire.
6 hours after finishing bowel preparation
Cecal intubation rate
Time Frame: 1 hour after the colonoscopy
Ratio of successful cecal intubations in each study arm
1 hour after the colonoscopy
Adenoma detection rate
Time Frame: 1 hour after the colonoscopy
Ratio of polyps and adenomas detected in each study arm
1 hour after the colonoscopy
Polyp detection rate
Time Frame: 1 hour after the colonoscopy
Ratio of polyps and adenomas detected in each study arm
1 hour after the colonoscopy
Abdominal pain
Time Frame: 6 hours after finishing bowel preparation
Each participant will rate his/her experience in an analogue visual scale
6 hours after finishing bowel preparation
Nausea
Time Frame: 6 hours after finishing bowel preparation
Each participant will rate his/her experience in an analogue visual scale
6 hours after finishing bowel preparation
Hunger
Time Frame: 6 hours after finishing bowel preparation
Each participant will rate his/her experience in an analogue visual scale
6 hours after finishing bowel preparation
Bloating
Time Frame: 6 hours after finishing bowel preparation
Each participant will rate his/her experience in an analogue visual scale
6 hours after finishing bowel preparation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marco Antonio Alvarez González, MD, PhD, Parc de Salut Mar

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

March 17, 2015

First Submitted That Met QC Criteria

March 24, 2015

First Posted (Estimate)

March 30, 2015

Study Record Updates

Last Update Posted (Actual)

February 15, 2017

Last Update Submitted That Met QC Criteria

February 14, 2017

Last Verified

February 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Diseases

Clinical Trials on Low-residue diet

3
Subscribe